Actual Weight Chemo Doses may Improve Ovarian Cancer Survival Rate

by: cancercompass

A recent study suggests that properly calculating chemotherapy treatment to body weight may minimize the impact of obesity on ovarian cancer survival.

Researchers at the Comprehensive Cancer Center on the campus of the University of Alabama Birmingham (UAB) found survival rates were the same for slim and obese women if their chemotherapy doses corresponded with their individual weight.

These findings, published online recently in the journal of Gynecologic Oncology, contradict earlier research showing obese women have lower ovarian cancer survival rates. Researchers said "ideal" body weight is often the guide used for dosing chemotherapy when "actual" body weight is more effective.

UAB researchers analyzed medical records from 304 patients diagnosed in a similar stage of aggressive epithelial ovarian cancer and had surgery followed by chemotherapy.

UAB researchers suggest it is possible to use actual weight, body mass index (BMI) and other factors to remove obesity as a hindrance to survival, but they also warn that obesity still puts women at increased risks for complications.

This isn't the first study to suggest body composition plays a role in cancer survival. Read: Lean Muscle Mass Helps Obese Cancer Patients.